v3.26.1
Redeemable Common Stock and Shareholders' Deficit - Summary of Warrant Activity Associated with Equity Financings (Details) - Warrants - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Warrants Outstanding, Beginning balance 1,376,056  
Number of Warrants Outstanding Ending balance 1,376,056 1,376,056
Number of Warrants Outstanding, Exercisable 927,566  
Weighted Average Contractual Term (in years), Outstanding 5 years 5 years 6 months 3 days
Weighted Average Contractual Term (in years), Exercisable 4 years 11 months 1 day  
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance $ 5.91  
Weighted Average Exercise Price Per Share, Outstanding, Ending balance 5.91 $ 5.91
Weighted Average Exercise Price Per Share, Exercisable $ 5.79  
Equity Financing    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Warrants Outstanding, Beginning balance 9,787,769  
Number of Warrants Outstanding, Granted 1,327,941  
Number of Warrants Outstanding Ending balance 11,115,710 9,787,769
Number of Warrants Outstanding, Exercisable 11,115,710  
Weighted Average Contractual Term (in years), Granted 5 years  
Weighted Average Contractual Term (in years), Outstanding 5 years 7 months 24 days 6 years 2 months 26 days
Weighted Average Contractual Term (in years), Exercisable 5 years 7 months 24 days  
Aggregate Intrinsic Value, Outstanding, Beginning balance $ 373  
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance $ 2.8  
Weighted Average Exercise Price Per Share, Granted 1.45  
Weighted Average Exercise Price Per Share, Outstanding, Ending balance 2.08 $ 2.8
Weighted Average Exercise Price Per Share, Exercisable $ 2.08